These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||
|
(State or other jurisdiction of incorporation or organization)
|
(I.R.S. Employer Identification No.)
|
|||||||
|
|
|
|||||||
| (Address of principal executive offices) |
(Zip Code)
|
|||||||
| Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||||||
|
|
|
|
||||||
|
|
☒
|
Accelerated filer | ☐ | ||||||||
|
Non-accelerated filer
|
☐
|
Smaller reporting company
|
|
||||||||
|
Emerging growth company
|
|
||||||||||
|
Page
|
||||||||
|
Item 1.
|
||||||||
|
Item 2.
|
||||||||
|
Item 3.
|
||||||||
|
Item 4.
|
||||||||
|
Item 1.
|
||||||||
|
Item 1A.
|
||||||||
|
Item 2.
|
||||||||
|
Item 3.
|
||||||||
|
Item 4.
|
||||||||
|
Item 5.
|
||||||||
|
Item 6.
|
||||||||
| Glossary of Terms | ||||||||
| The following terms or acronyms used in this Quarterly Report on Form 10-Q are defined below: | ||||||||
| Term or Acronym | Definition | |||||||
| 2022 10-K | 2022 Annual Report on Form 10-K filed with the SEC on March 1, 2023 | |||||||
| 2025 Unsecured Notes | 8.625% senior unsecured notes due 2025 issued by LNWI | |||||||
| 2028 Unsecured Notes | 7.000% senior unsecured notes due 2028 issued by LNWI | |||||||
| 2029 Unsecured Notes | 7.250% senior unsecured notes due 2029 issued by LNWI | |||||||
| 2031 Unsecured Notes | 7.500% senior unsecured notes due 2031 issued by LNWI | |||||||
| AEBITDA | Adjusted EBITDA, our performance measure of profit or loss for our business segments | |||||||
| ASC | Accounting Standards Codification | |||||||
| ASU | Accounting Standards Update | |||||||
| ASX | Australian Securities Exchange | |||||||
| CDIs | CHESS Depositary Interests, instruments traded on the ASX | |||||||
| CMS | casino-management system | |||||||
| COVID-19 | Coronavirus disease first identified in 2019 (declared a pandemic by the World Health Organization on March 11, 2020), the resulting pandemic and the associated impacts on the macroeconomic environment in general and our business environment specifically | |||||||
| D&A | depreciation, amortization and impairments (excluding goodwill) | |||||||
|
Divested Businesses or Divestitures
|
The Lottery Business and Sports Betting Business combined or the sales of these, as appropriate within the context | |||||||
| Exchange Act | Securities Exchange Act of 1934, as amended | |||||||
| KPIs | Key Performance Indicators | |||||||
| L&W | Light & Wonder, Inc. | |||||||
| LBO | licensed betting office | |||||||
| LNWI | Light and Wonder International, Inc., a wholly-owned subsidiary of L&W and successor to Scientific Games International, Inc. | |||||||
| LNWI Credit Agreement |
That certain credit agreement, dated as of April 14, 2022, among LNWI, as the borrower, L&W, as a guarantor, the lenders from time to time party thereto, JPMorgan Chase Bank, N.A., as Administrative Agent, Collateral Agent and Swingline Lender, BofA Securities, Inc., BNP Paribas Securities Corp., Deutsche Bank Securities Inc., Fifth Third Bank, National Association, Barclays Bank PLC, Citizens Bank, N.A., Goldman Sachs Bank USA, Morgan Stanley Senior Funding, Inc., Royal Bank of Canada, Truist Securities, Inc., Credit Suisse Loan Funding LLC and Macquarie Capital (USA) Inc. as Lead Arrangers and Joint Bookrunners, as amended, restated, amended and restated, supplemented or otherwise modified from time to time
|
|||||||
| LNWI Revolver | Revolving credit facility with aggregate commitments of $750 million extended pursuant to the LNWI Credit Agreement | |||||||
| LNWI Term Loan B | Term loan facility, issued pursuant to the LNWI Credit Agreement | |||||||
| Lottery Business |
Our prior operating business segment that provided instant and draw‑based lottery products, lottery systems and lottery content and services to lottery operators wagering solutions to various gaming entities. This business segment was divested during the second quarter of 2022 and is included in discontinued operations in our financial statements
|
|||||||
| Note | a note in the Notes to Condensed Consolidated Financial Statements in this Quarterly Report on Form 10-Q, unless otherwise indicated | |||||||
| Participation | refers to gaming machines provided to customers through service or leasing arrangements in which we earn revenues and are paid based on: (1) a percentage of the amount wagered less payouts; (2) fixed daily-fees; (3) a percentage of the amount wagered; or (4) a combination of (2) and (3) | |||||||
| R&D | research and development | |||||||
| RSU | restricted stock unit | |||||||
| SciPlay | SciPlay Corporation | |||||||
| SciPlay Revolver | $150 million revolving credit facility agreement entered into by SciPlay Holding Company, LLC, a subsidiary of SciPlay Corporation, that matures in May 2024 | |||||||
| SEC | Securities and Exchange Commission | |||||||
| Securities Act | Securities Act of 1933, as amended | |||||||
| Senior Notes or Unsecured Notes | refers to the 2028 Unsecured Notes, 2029 Unsecured Notes and 2031 Unsecured Notes, collectively | |||||||
| SG&A | selling, general and administrative | |||||||
| Shufflers | various models of automatic card shufflers, deck checkers and roulette chip sorters | |||||||
| SOFR | Secured Overnight Financing Rate | |||||||
| Sports Betting Business |
Our prior line of business that provided sports betting services which enable customers to operate sports books, including betting markets across both fixed-odds and pari-mutual betting styles, a distribution platform, full gaming process support services and brand and player management. This business was divested during the third quarter of 2022 and is included in discontinued operations in our financial statements
|
|||||||
| U.S. GAAP | accounting principles generally accepted in the U.S. | |||||||
| U.S. jurisdictions | the 50 states in the U.S. plus the District of Columbia, U.S. Virgin Islands and Puerto Rico | |||||||
| VGT | video gaming terminal | |||||||
| VLT | video lottery terminal | |||||||
and James Bond indicia © 1962-2023 Danjaq, LLC and MGM.
and all other James Bond related trademarks are trademarks of Danjaq, LLC. All Rights Reserved.
| Three Months Ended September 30, | Nine Months Ended September 30, | ||||||||||||||||||||||
| 2023 | 2022 | 2023 | 2022 | ||||||||||||||||||||
| Revenue: | |||||||||||||||||||||||
| Services | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
| Products |
|
|
|
|
|||||||||||||||||||
| Total revenue |
|
|
|
|
|||||||||||||||||||
| Operating expenses: | |||||||||||||||||||||||
|
Cost of services
(1)
|
|
|
|
|
|||||||||||||||||||
|
Cost of products
(1)
|
|
|
|
|
|||||||||||||||||||
| Selling, general and administrative |
|
|
|
|
|||||||||||||||||||
| Research and development |
|
|
|
|
|||||||||||||||||||
| Depreciation, amortization and impairments |
|
|
|
|
|||||||||||||||||||
| Restructuring and other |
|
|
|
|
|||||||||||||||||||
| Operating income |
|
|
|
|
|||||||||||||||||||
| Other (expense) income: | |||||||||||||||||||||||
| Interest expense |
(
|
(
|
(
|
(
|
|||||||||||||||||||
| Loss on debt financing transactions |
(
|
|
(
|
(
|
|||||||||||||||||||
| Gain on remeasurement of debt and other |
|
|
|
|
|||||||||||||||||||
| Other income, net |
|
|
|
|
|||||||||||||||||||
| Total other expense, net |
(
|
(
|
(
|
(
|
|||||||||||||||||||
|
Net income (loss) from continuing operations before income taxes
|
|
|
|
(
|
|||||||||||||||||||
| Income tax expense |
(
|
(
|
(
|
(
|
|||||||||||||||||||
|
Net income (loss) from continuing operations
|
|
|
|
(
|
|||||||||||||||||||
|
Net income from discontinued operations, net of tax
(2)
|
|
|
|
|
|||||||||||||||||||
| Net income |
|
|
|
|
|||||||||||||||||||
| Less: Net income attributable to noncontrolling interest |
|
|
|
|
|||||||||||||||||||
| Net income attributable to L&W | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
| Per Share - Basic: | |||||||||||||||||||||||
|
Net income (loss) from continuing operations
|
$ |
|
$ |
|
$ |
|
$ |
(
|
|||||||||||||||
| Net income from discontinued operations |
|
|
|
|
|||||||||||||||||||
| Net income attributable to L&W | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
| Per Share - Diluted: | |||||||||||||||||||||||
|
Net income (loss) from continuing operations
|
$ |
|
$ |
|
$ |
|
$ |
(
|
|||||||||||||||
| Net income from discontinued operations |
|
|
|
|
|||||||||||||||||||
| Net income attributable to L&W | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
| Weighted average number of shares used in per share calculations: |
|
|
|||||||||||||||||||||
| Basic shares |
|
|
|
|
|||||||||||||||||||
| Diluted shares |
|
|
|
|
|||||||||||||||||||
|
|
|||||||||||||||||||||||
|
|
|||||||||||||||||||||||
|
See accompanying notes to condensed consolidated financial statements.
|
|||||||||||||||||||||||
| Three Months Ended September 30, | Nine Months Ended September 30, | ||||||||||||||||||||||
| 2023 | 2022 | 2023 | 2022 | ||||||||||||||||||||
| Net income | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
| Other comprehensive loss: | |||||||||||||||||||||||
| Foreign currency translation loss, net of tax |
(
|
(
|
(
|
(
|
|||||||||||||||||||
| Derivative financial instruments unrealized gain, net of tax |
|
|
|
|
|||||||||||||||||||
| Other comprehensive loss from continuing operations |
(
|
(
|
(
|
(
|
|||||||||||||||||||
| Other comprehensive income from discontinued operations |
|
|
|
|
|||||||||||||||||||
| Total comprehensive income |
|
|
|
|
|||||||||||||||||||
| Less: comprehensive income attributable to noncontrolling interest |
|
|
|
|
|||||||||||||||||||
| Comprehensive income attributable to L&W | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
| See accompanying notes to condensed consolidated financial statements. | |||||||||||||||||||||||
| As of | |||||||||||
| September 30, 2023 | December 31, 2022 | ||||||||||
|
ASSETS
|
|||||||||||
| Current assets: | |||||||||||
| Cash and cash equivalents | $ |
|
$ |
|
|||||||
| Restricted cash |
|
|
|||||||||
|
Receivables, net of allowance for credit losses of $
|
|
|
|||||||||
| Inventories |
|
|
|||||||||
| Prepaid expenses, deposits and other current assets |
|
|
|||||||||
| Total current assets |
|
|
|||||||||
| Non-current assets: | |||||||||||
| Restricted cash |
|
|
|||||||||
|
Receivables, net of allowance for credit losses of $
|
|
|
|||||||||
| Property and equipment, net |
|
|
|||||||||
| Operating lease right-of-use assets |
|
|
|||||||||
| Goodwill |
|
|
|||||||||
| Intangible assets, net |
|
|
|||||||||
| Software, net |
|
|
|||||||||
| Deferred income taxes |
|
|
|||||||||
| Other assets |
|
|
|||||||||
| Total assets | $ |
|
$ |
|
|||||||
|
LIABILITIES AND STOCKHOLDERS’ EQUITY
|
|||||||||||
|
Current liabilities:
|
|||||||||||
|
Current portion of long-term debt
|
$ |
|
$ |
|
|||||||
|
Accounts payable
|
|
|
|||||||||
|
Accrued liabilities
|
|
|
|||||||||
| Income taxes payable |
|
|
|||||||||
|
Total current liabilities
|
|
|
|||||||||
|
Deferred income taxes
|
|
|
|||||||||
|
Operating lease liabilities
|
|
|
|||||||||
|
Other long-term liabilities
|
|
|
|||||||||
|
Long-term debt, excluding current portion
|
|
|
|||||||||
|
Total liabilities
|
|
|
|||||||||
|
Commitments and contingencies (Note 16)
|
|
|
|||||||||
|
|
|||||||||||
|
Common stock, par value $
|
|
|
|||||||||
|
Additional paid-in capital
|
|
|
|||||||||
|
Retained earnings
|
|
|
|||||||||
|
Treasury stock, at cost,
|
(
|
(
|
|||||||||
|
Accumulated other comprehensive loss
|
(
|
(
|
|||||||||
|
Total L&W stockholders’ equity
|
|
|
|||||||||
|
Noncontrolling interest
|
|
|
|||||||||
|
Total stockholders’ equity
|
|
|
|||||||||
|
Total liabilities and stockholders’ equity
|
$ |
|
$ |
|
|||||||
| See accompanying notes to condensed consolidated financial statements. | |||||||||||
| Nine Months Ended September 30, | |||||||||||
| 2023 | 2022 | ||||||||||
|
Cash flows from operating activities:
|
|||||||||||
|
Net income
|
$ |
|
$ |
|
|||||||
| Less: Income from discontinued operations, net of tax |
|
(
|
|||||||||
|
Adjustments to reconcile net income (loss) from continuing operations to net cash provided by (used in) operating activities from continuing operations
|
|
|
|||||||||
|
Changes in working capital accounts, excluding the effects of acquisitions
|
(
|
(
|
|||||||||
|
Changes in deferred income taxes and other
|
(
|
|
|||||||||
|
Net cash provided by (used in) operating activities from continuing operations
|
|
(
|
|||||||||
|
Net cash provided by operating activities from discontinued operations
|
|
|
|||||||||
| Net cash provided by (used in) operating activities |
|
(
|
|||||||||
|
Cash flows from investing activities:
|
|||||||||||
| Capital expenditures |
(
|
(
|
|||||||||
| Acquisitions of businesses, net of cash acquired |
(
|
(
|
|||||||||
| Proceeds from settlement of cross-currency interest rate swaps and other |
(
|
|
|||||||||
|
Net cash used in investing activities from continuing operations
|
(
|
(
|
|||||||||
|
Net cash (used in) provided by investing activities from discontinued operations
(1)
|
(
|
|
|||||||||
| Net cash (used in) provided by investing activities |
(
|
|
|||||||||
|
Cash flows from financing activities:
|
|||||||||||
|
Borrowings under revolving credit facilities
|
|
|
|||||||||
|
Repayments under revolving credit facilities
|
|
(
|
|||||||||
|
Proceeds from issuance of senior notes and term loans
|
|
|
|||||||||
| Repayment of notes and term loans (including redemption premium) |
(
|
(
|
|||||||||
| Payments on long-term debt |
(
|
(
|
|||||||||
|
Payments of debt issuance and deferred financing costs
|
(
|
(
|
|||||||||
|
Payments on license obligations
|
(
|
(
|
|||||||||
| Purchase of L&W common stock |
(
|
(
|
|||||||||
| Purchase of SciPlay’s Class A common stock |
(
|
(
|
|||||||||
| Net redemptions of common stock under stock-based compensation plans and other |
(
|
(
|
|||||||||
|
Net cash used in financing activities from continuing operations
|
(
|
(
|
|||||||||
| Net cash used in financing activities from discontinued operations |
|
(
|
|||||||||
| Net cash used in financing activities |
(
|
(
|
|||||||||
| Effect of exchange rate changes on cash, cash equivalents and restricted cash |
(
|
(
|
|||||||||
|
(Decrease) increase in cash, cash equivalents and restricted cash
|
(
|
|
|||||||||
| Cash, cash equivalents and restricted cash, beginning of period |
|
|
|||||||||
|
Cash, cash equivalents and restricted cash, end of period
|
|
|
|||||||||
| Less: Cash, cash equivalents and restricted cash of discontinued operations |
|
|
|||||||||
| Cash, cash equivalents and restricted cash of continuing operations, end of period | $ |
|
$ |
|
|||||||
|
Supplemental cash flow information:
|
|||||||||||
| Cash paid for interest | $ |
|
$ |
|
|||||||
|
Income taxes paid
|
|
|
|||||||||
| Distributed earnings from equity investments |
|
|
|||||||||
| Cash paid for contingent consideration included in operating activities |
|
|
|||||||||
|
Supplemental non-cash transactions:
|
|||||||||||
|
Non-cash interest expense
|
$ |
|
$ |
|
|||||||
| Fair value of securities received in sale of discontinued operations |
|
|
|||||||||
|
|
|||||||||||
| See accompanying notes to condensed consolidated financial statements. | |||||||||||
|
Three Months Ended
September 30, 2022 |
Nine Months Ended
September 30, 2022 |
||||||||||||||||||||||
| Total revenue | $ |
|
$ |
|
|||||||||||||||||||
| Total cost of revenue |
|
|
|||||||||||||||||||||
|
Other operating expenses
(1)
|
|
|
|||||||||||||||||||||
| Operating (loss) income |
(
|
|
|||||||||||||||||||||
| Total other income, net |
|
|
|||||||||||||||||||||
|
Net (loss) income from discontinued operations before income taxes
|
(
|
|
|||||||||||||||||||||
| Gain on sale of discontinued operations before income taxes |
|
|
|||||||||||||||||||||
| Total net income from discontinued operations before income taxes |
|
|
|||||||||||||||||||||
| Income tax expense |
(
|
(
|
|||||||||||||||||||||
| Net income from discontinued operations, net of tax included in the consolidated statement of operations | $ |
|
$ |
|
|||||||||||||||||||
|
|
|||||||||||||||||||||||
| Three Months Ended September 30, | Nine Months Ended September 30, | ||||||||||||||||||||||
| 2023 | 2022 | 2023 | 2022 | ||||||||||||||||||||
| Gaming | |||||||||||||||||||||||
| Gaming operations | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
| Gaming machine sales |
|
|
|
|
|||||||||||||||||||
| Gaming systems |
|
|
|
|
|||||||||||||||||||
| Table products |
|
|
|
|
|||||||||||||||||||
| Total | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
| SciPlay | |||||||||||||||||||||||
| Mobile in-app purchases | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
|
Web in-app purchases and other
(1)
|
|
|
|
|
|||||||||||||||||||
| Total | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
| iGaming | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
|
|
|||||||||||||||||||||||
| Nine Months Ended September 30, 2023 | ||||||||||||||
|
Contract liability balance, beginning of period
(1)
|
$ |
|
||||||||||||
| Liabilities recognized during the period |
|
|||||||||||||
| Amounts recognized in revenue from beginning balance |
(
|
|||||||||||||
|
Contract liability balance, end of period
(1)
|
$ |
|
||||||||||||
|
|
||||||||||||||
| Receivables |
Contract Assets
(1)
|
||||||||||
| Beginning of period balance | $ |
|
$ |
|
|||||||
|
End of period balance, September 30, 2023
|
|
|
|||||||||
|
|
|||||||||||
| Three Months Ended September 30, 2023 | |||||||||||||||||||||||||||||
| Gaming | SciPlay | iGaming |
Unallocated and Reconciling Items
(1)
|
Total | |||||||||||||||||||||||||
|
Total revenue
|
$ | 465 | $ | 196 | $ | 70 | $ |
|
$ |
|
|||||||||||||||||||
|
AEBITDA
(2)
|
|
|
|
(
|
$ |
|
|||||||||||||||||||||||
|
Reconciling items to net income from continuing operations before income taxes:
|
|||||||||||||||||||||||||||||
|
D&A
|
(
|
(
|
(
|
(
|
(
|
||||||||||||||||||||||||
|
Restructuring and other
|
(
|
(
|
(
|
(
|
(
|
||||||||||||||||||||||||
|
Interest expense
|
(
|
(
|
|||||||||||||||||||||||||||
| Loss on debt financing transactions |
(
|
(
|
|||||||||||||||||||||||||||
|
Other income, net
|
|
|
|||||||||||||||||||||||||||
|
Stock-based compensation
|
(
|
(
|
|||||||||||||||||||||||||||
|
Net income from continuing operations before income taxes
|
$ |
|
|||||||||||||||||||||||||||
|
|
|||||||||||||||||||||||||||||
|
|
|||||||||||||||||||||||||||||
| Three Months Ended September 30, 2022 | |||||||||||||||||||||||||||||||||||
| Gaming | SciPlay | iGaming |
Unallocated and Reconciling Items
(1)
|
Total | |||||||||||||||||||||||||||||||
|
Total revenue
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||||||||||||
|
AEBITDA
(2)
|
|
|
|
(
|
$ |
|
|||||||||||||||||||||||||||||
|
Reconciling items to net income from continuing operations before income taxes:
|
|||||||||||||||||||||||||||||||||||
|
D&A
|
(
|
(
|
(
|
(
|
(
|
||||||||||||||||||||||||||||||
|
Restructuring and other
|
(
|
(
|
|
(
|
(
|
||||||||||||||||||||||||||||||
|
Interest expense
|
(
|
(
|
|||||||||||||||||||||||||||||||||
| Other income, net |
|
|
|||||||||||||||||||||||||||||||||
| Stock-based compensation |
(
|
(
|
|||||||||||||||||||||||||||||||||
|
Net income from continuing operations before income taxes
|
$ |
|
|||||||||||||||||||||||||||||||||
| (1) Includes amounts not allocated to the business segments (including corporate costs) and items to reconcile the total business segments AEBITDA to our consolidated net income from continuing operations before income taxes. | |||||||||||||||||||||||||||||||||||
|
(2) AEBITDA is described in footnote (2) to the first table in this Note 4.
|
|||||||||||||||||||||||||||||||||||
| Nine Months Ended September 30, 2023 | |||||||||||||||||||||||||||||||||||
| Gaming | SciPlay | iGaming |
Unallocated and Reconciling Items
(1)
|
Total | |||||||||||||||||||||||||||||||
|
Total revenue
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||||||||||||
|
AEBITDA
(2)
|
|
|
|
(
|
$ |
|
|||||||||||||||||||||||||||||
|
Reconciling items to net income from continuing operations before income taxes:
|
|||||||||||||||||||||||||||||||||||
|
D&A
|
(
|
(
|
(
|
(
|
(
|
||||||||||||||||||||||||||||||
|
Restructuring and other
|
(
|
(
|
(
|
(
|
(
|
||||||||||||||||||||||||||||||
|
Interest expense
|
(
|
(
|
|||||||||||||||||||||||||||||||||
| Loss on debt financing transactions |
(
|
(
|
|||||||||||||||||||||||||||||||||
|
Other income, net
|
|
|
|||||||||||||||||||||||||||||||||
|
Stock-based compensation
|
(
|
(
|
|||||||||||||||||||||||||||||||||
|
Net income from continuing operations before income taxes
|
$ |
|
|||||||||||||||||||||||||||||||||
| (1) Includes amounts not allocated to the business segments (including corporate costs) and items to reconcile the total business segments AEBITDA to our consolidated net income from continuing operations before income taxes. | |||||||||||||||||||||||||||||||||||
| (2) AEBITDA is described in footnote (2) to the first table in this Note 4. | |||||||||||||||||||||||||||||||||||
| Nine Months Ended September 30, 2022 | |||||||||||||||||||||||||||||||||||
| Gaming | SciPlay | iGaming |
Unallocated and Reconciling Items
(1)
|
Total | |||||||||||||||||||||||||||||||
|
Total revenue
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||||||||||||
|
AEBITDA
(2)
|
|
|
|
(
|
$ |
|
|||||||||||||||||||||||||||||
|
Reconciling items to net loss from continuing operations before income taxes:
|
|||||||||||||||||||||||||||||||||||
|
D&A
|
(
|
(
|
(
|
(
|
(
|
||||||||||||||||||||||||||||||
|
Restructuring and other
|
(
|
(
|
(
|
(
|
(
|
||||||||||||||||||||||||||||||
|
Interest expense
|
(
|
(
|
|||||||||||||||||||||||||||||||||
|
Loss on debt financing transactions
|
(
|
(
|
|||||||||||||||||||||||||||||||||
| Gain on remeasurement of debt and other |
|
|
|||||||||||||||||||||||||||||||||
|
Other income, net
|
|
|
|||||||||||||||||||||||||||||||||
| Stock-based compensation |
(
|
(
|
|||||||||||||||||||||||||||||||||
|
Net loss from continuing operations before income taxes
|
$ |
(
|
|||||||||||||||||||||||||||||||||
| (1) Includes amounts not allocated to the business segments (including corporate costs) and items to reconcile the total business segments AEBITDA to our consolidated net loss from continuing operations before income taxes. | |||||||||||||||||||||||||||||||||||
| (2) AEBITDA is described in footnote (2) to the first table in this Note 4. | |||||||||||||||||||||||||||||||||||
| Three Months Ended September 30, | Nine Months Ended September 30, | ||||||||||||||||||||||
| 2023 | 2022 | 2023 | 2022 | ||||||||||||||||||||
| Employee severance and related | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
|
Strategic review and related
(1)
|
|
|
|
|
|||||||||||||||||||
|
Contingent acquisition consideration
(2)
|
|
|
|
|
|||||||||||||||||||
| Restructuring, integration and other |
|
|
|
|
|||||||||||||||||||
| Total | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
|
|
|||||||||||||||||||||||
|
|
|||||||||||||||||||||||
| As of | |||||||||||
| September 30, 2023 | December 31, 2022 | ||||||||||
| Current: | |||||||||||
|
Receivables
|
$ |
|
$ |
|
|||||||
|
Allowance for credit losses
|
(
|
(
|
|||||||||
|
Current receivables, net
|
|
|
|||||||||
| Long-term: | |||||||||||
|
Receivables
|
|
|
|||||||||
|
Allowance for credit losses
|
(
|
(
|
|||||||||
| Long-term receivables, net |
|
|
|||||||||
|
Total receivables, net
|
$ |
|
$ |
|
|||||||
| As of | |||||||||||||||||||||||
| September 30, 2023 | Balances over 90 days past due | December 31, 2022 | Balances over 90 days past due | ||||||||||||||||||||
| Receivables: | |||||||||||||||||||||||
| U.S. and Canada | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
| International |
|
|
|
|
|||||||||||||||||||
| Total receivables |
|
|
|
|
|||||||||||||||||||
| Receivables allowance: | |||||||||||||||||||||||
| U.S. and Canada |
(
|
(
|
(
|
(
|
|||||||||||||||||||
| International |
(
|
(
|
(
|
(
|
|||||||||||||||||||
| Total receivables allowance |
(
|
(
|
(
|
(
|
|||||||||||||||||||
| Receivables, net | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
| 2023 | 2022 | ||||||||||||||||||||||
| Total | U.S. and Canada | International | Total | ||||||||||||||||||||
|
Beginning allowance for credit losses
|
$ |
(
|
$ |
(
|
$ |
(
|
$ |
(
|
|||||||||||||||
|
Provision
|
(
|
(
|
|
(
|
|||||||||||||||||||
|
Charge-offs and recoveries
|
|
|
|
|
|||||||||||||||||||
| Allowance for credit losses as of March 31 | $ |
(
|
$ |
(
|
$ |
(
|
$ |
(
|
|||||||||||||||
|
Provision
|
(
|
|
(
|
(
|
|||||||||||||||||||
|
Charge-offs and recoveries
|
|
|
|
|
|||||||||||||||||||
| Allowance for credit losses as of June 30 | $ |
(
|
$ |
(
|
$ |
(
|
$ |
(
|
|||||||||||||||
| Provision |
|
|
|
|
|||||||||||||||||||
| Charge-offs and recoveries |
|
|
|
|
|||||||||||||||||||
| Allowance for credit losses as of September 30 | $ |
(
|
$ |
(
|
$ |
(
|
$ |
(
|
|||||||||||||||
|
As of September 30, 2023
|
|||||||||||||||||||||||||||||||||||||||||
| Total | Current | Balances over 90 days past due | |||||||||||||||||||||||||||||||||||||||
| Receivables | $ |
|
$ |
|
$ |
|
|||||||||||||||||||||||||||||||||||
| Allowance for credit losses |
(
|
(
|
(
|
||||||||||||||||||||||||||||||||||||||
| Receivables, net | $ |
|
$ |
|
$ |
|
|||||||||||||||||||||||||||||||||||
| As of | |||||||||||
| September 30, 2023 | December 31, 2022 | ||||||||||
|
Parts and work-in-process
|
$ |
|
$ |
|
|||||||
|
Finished goods
|
|
|
|||||||||
|
Total inventories
|
$ |
|
$ |
|
|||||||
| As of | |||||||||||
| September 30, 2023 | December 31, 2022 | ||||||||||
| Land | $ |
|
$ |
|
|||||||
| Buildings and leasehold improvements |
|
|
|||||||||
| Gaming machinery and equipment |
|
|
|||||||||
| Furniture and fixtures |
|
|
|||||||||
| Construction in progress |
|
|
|||||||||
| Other property and equipment |
|
|
|||||||||
| Less: accumulated depreciation |
(
|
(
|
|||||||||
| Total property and equipment, net | $ |
|
$ |
|
|||||||
| Three Months Ended September 30, | Nine Months Ended September 30, | ||||||||||||||||||||||
| 2023 | 2022 | 2023 | 2022 | ||||||||||||||||||||
| Depreciation expense | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
| As of | |||||||||||||||||||||||||||||||||||||||||
| September 30, 2023 | December 31, 2022 | ||||||||||||||||||||||||||||||||||||||||
|
Gross Carrying Value
|
Accumulated Amortization
|
Net Balance
|
Gross Carrying Value
|
Accumulated Amortization
|
Net Balance
|
||||||||||||||||||||||||||||||||||||
|
Amortizable intangible assets:
|
|||||||||||||||||||||||||||||||||||||||||
| Customer relationships | $ |
|
$ |
(
|
$ |
|
$ |
|
$ |
(
|
$ |
|
|||||||||||||||||||||||||||||
| Intellectual property |
|
(
|
|
|
(
|
|
|||||||||||||||||||||||||||||||||||
| Licenses |
|
(
|
|
|
(
|
|
|||||||||||||||||||||||||||||||||||
| Brand names |
|
(
|
|
|
(
|
|
|||||||||||||||||||||||||||||||||||
| Trade names |
|
(
|
|
|
(
|
|
|||||||||||||||||||||||||||||||||||
| Patents and other |
|
(
|
|
|
(
|
|
|||||||||||||||||||||||||||||||||||
| Total intangible assets | $ |
|
$ |
(
|
$ |
|
$ |
|
$ |
(
|
$ |
|
|||||||||||||||||||||||||||||
| Three Months Ended September 30, | Nine Months Ended September 30, | ||||||||||||||||||||||
| 2023 | 2022 | 2023 | 2022 | ||||||||||||||||||||
|
Amortization expense
(1)
|
$ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
|
|
|||||||||||||||||||||||
|
Gaming
(1)
|
SciPlay | iGaming | Totals | |||||||||||||||||||||||||||||||||||
|
Balance as of December 31, 2022
|
$ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||||||||||||||
| Foreign currency adjustments |
(
|
(
|
(
|
(
|
||||||||||||||||||||||||||||||||||
|
Balance as of September 30, 2023
|
$ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||||||||||||||
|
|
||||||||||||||||||||||||||||||||||||||
| As of | |||||||||||
| September 30, 2023 | December 31, 2022 | ||||||||||
| Software | $ |
|
$ |
|
|||||||
| Accumulated amortization |
(
|
(
|
|||||||||
| Software, net | $ |
|
$ |
|
|||||||
| Three Months Ended September 30, | Nine Months Ended September 30, | ||||||||||||||||||||||
| 2023 | 2022 | 2023 | 2022 | ||||||||||||||||||||
| Amortization expense | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
| As of | |||||||||||||||||||||||||||||||||||
| September 30, 2023 | December 31, 2022 | ||||||||||||||||||||||||||||||||||
| Final Maturity | Rate(s) | Face value | Unamortized debt discount/premium and deferred financing costs, net | Book value | Book value | ||||||||||||||||||||||||||||||
| Senior Secured Credit Facilities: | |||||||||||||||||||||||||||||||||||
|
SciPlay Revolver
(1)
|
2024 | variable | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||||||||||||
| LNWI Revolver | 2027 | variable |
|
|
|
|
|||||||||||||||||||||||||||||
| LNWI Term Loan B | 2029 | variable |
|
(
|
|
|
|||||||||||||||||||||||||||||
| LNWI Senior Notes: | |||||||||||||||||||||||||||||||||||
| 2025 Unsecured Notes | 2025 |
|
|
|
|
|
|||||||||||||||||||||||||||||
| 2028 Unsecured Notes | 2028 |
|
|
(
|
|
|
|||||||||||||||||||||||||||||
| 2029 Unsecured Notes | 2029 |
|
|
(
|
|
|
|||||||||||||||||||||||||||||
| 2031 Unsecured Notes | 2031 |
|
|
(
|
|
|
|||||||||||||||||||||||||||||
| Other | — | — |
|
|
|
|
|||||||||||||||||||||||||||||
| Total long-term debt outstanding | $ |
|
$ |
(
|
$ |
|
$ |
|
|||||||||||||||||||||||||||
| Less: current portion of long-term debt |
(
|
(
|
|||||||||||||||||||||||||||||||||
| Long-term debt, excluding current portion | $ |
|
$ |
|
|||||||||||||||||||||||||||||||
|
Fair value of debt
(2)
|
$ |
|
|||||||||||||||||||||||||||||||||
|
|
|||||||||||||||||||||||||||||||||||
|
|
|||||||||||||||||||||||||||||||||||
| Three Months Ended September 30, | Nine Months Ended September 30, | ||||||||||||||||||||||
| 2023 | 2022 | 2023 | 2022 | ||||||||||||||||||||
| Repayment of principal balance at premium | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
| Unamortized debt discount and deferred financing costs, net |
|
|
|
|
|||||||||||||||||||
| Total loss on debt refinancing transactions | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
| Three Months Ended September 30, | Nine Months Ended September 30, | ||||||||||||||||||||||
| 2023 | 2022 | 2023 | 2022 | ||||||||||||||||||||
| Gain recorded in accumulated other comprehensive loss, net of tax | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
| Interest income (expense) recorded related to interest rate swap contracts |
|
(
|
|
(
|
|||||||||||||||||||
| Three Months Ended September 30, | Nine Months Ended September 30, | ||||||||||||||||||||||
| 2023 | 2022 | 2023 | 2022 | ||||||||||||||||||||
| Total interest expense which reflects the effects of cash flow hedges | $ |
(
|
$ |
(
|
$ |
(
|
$ |
(
|
|||||||||||||||
| Hedged item |
(
|
(
|
(
|
(
|
|||||||||||||||||||
| Derivative designated as hedging instrument |
|
|
|
|
|||||||||||||||||||
| As of | |||||||||||||||||
|
Balance Sheet Line Item
|
September 30, 2023 | December 31, 2022 | |||||||||||||||
| Interest rate swaps | Other assets | $ |
|
$ |
|
||||||||||||
| Total | Included in Accrued Liabilities | Included in Other Long-Term Liabilities | |||||||||||||||
|
Balance as of December 31, 2022
|
$ |
|
$ |
|
$ |
|
|||||||||||
| Payments |
(
|
||||||||||||||||
|
Fair value adjustments
(1)
|
|
||||||||||||||||
|
Other adjustments
(2)
|
(
|
||||||||||||||||
|
Balance as of September 30, 2023
|
$ |
|
$ |
|
$ |
|
|||||||||||
|
|
|||||||||||||||||
|
|
|||||||||||||||||
| Nine Months Ended September 30, 2023 | |||||||||||||||||||||||||||||||||||||||||
| Common Stock | Additional Paid in Capital | Retained Earnings | Treasury Stock | Accumulated Other Comprehensive Loss | Noncontrolling Interest | Total | |||||||||||||||||||||||||||||||||||
| January 1, 2023 | $ |
|
$ |
|
$ |
|
$ |
(
|
$ |
(
|
$ |
|
$ |
|
|||||||||||||||||||||||||||
| Settlement of liability awards | — |
|
— | — | — | — |
|
||||||||||||||||||||||||||||||||||
| Vesting of RSUs, net of tax withholdings and other | — |
(
|
— | — | — | — |
(
|
||||||||||||||||||||||||||||||||||
| Purchase of treasury stock | — | — | — |
(
|
— | — |
(
|
||||||||||||||||||||||||||||||||||
| Purchase of SciPlay’s Class A common stock | — |
(
|
— | — | — | — |
(
|
||||||||||||||||||||||||||||||||||
| Stock-based compensation | — |
|
— | — | — | — |
|
||||||||||||||||||||||||||||||||||
| Net income | — | — |
|
— | — |
|
|
||||||||||||||||||||||||||||||||||
| Other comprehensive income | — | — | — | — |
|
— |
|
||||||||||||||||||||||||||||||||||
| March 31, 2023 | $ |
|
$ |
|
$ |
|
$ |
(
|
$ |
(
|
$ |
|
$ |
|
|||||||||||||||||||||||||||
| Vesting of RSUs, net of tax withholdings and other | — |
|
— | — | — | — |
|
||||||||||||||||||||||||||||||||||
| Purchase of treasury stock | — | — | — |
(
|
— | — |
(
|
||||||||||||||||||||||||||||||||||
| Purchase of SciPlay’s Class A common stock | — |
(
|
— | — | — |
|
(
|
||||||||||||||||||||||||||||||||||
| Stock-based compensation | — |
|
— | — | — | — |
|
||||||||||||||||||||||||||||||||||
| Net (loss) income | — | — |
(
|
— | — |
|
|
||||||||||||||||||||||||||||||||||
| Other comprehensive income | — | — | — | — |
|
— |
|
||||||||||||||||||||||||||||||||||
| June 30, 2023 | $ |
|
$ |
|
$ |
|
$ |
(
|
$ |
(
|
$ |
|
$ |
|
|||||||||||||||||||||||||||
| Vesting of RSUs, net of tax withholdings and other | — |
|
— | — | — | — |
|
||||||||||||||||||||||||||||||||||
|
Purchase of treasury stock
(1)
|
— | — | — |
(
|
— | — |
(
|
||||||||||||||||||||||||||||||||||
| Stock-based compensation | — |
|
— | — | — | — |
|
||||||||||||||||||||||||||||||||||
| Net income | — | — |
|
— | — |
|
|
||||||||||||||||||||||||||||||||||
| Other comprehensive loss | — | — | — | — |
(
|
— |
(
|
||||||||||||||||||||||||||||||||||
| September 30, 2023 | $ |
|
$ |
|
$ |
|
$ |
(
|
$ |
(
|
$ |
|
$ |
|
|||||||||||||||||||||||||||
|
|
|||||||||||||||||||||||||||||||||||||||||
| Nine Months Ended September 30, 2022 | |||||||||||||||||||||||||||||||||||||||||
| Common Stock | Additional Paid in Capital | Retained Earnings (Accumulated Loss) | Treasury Stock | Accumulated Other Comprehensive Loss | Noncontrolling Interest | Total | |||||||||||||||||||||||||||||||||||
| January 1, 2022 | $ |
|
$ |
|
$ |
(
|
$ |
(
|
$ |
(
|
$ |
|
$ |
(
|
|||||||||||||||||||||||||||
| Settlement of liability awards | — |
|
— | — | — | — |
|
||||||||||||||||||||||||||||||||||
| Vesting of RSUs, net of tax withholdings and other | — |
(
|
— | — | — | — |
(
|
||||||||||||||||||||||||||||||||||
| Purchase of treasury stock | — | — | — |
(
|
— | — |
(
|
||||||||||||||||||||||||||||||||||
| Stock-based compensation | — |
|
— | — | — | — |
|
||||||||||||||||||||||||||||||||||
| Net income | — | — |
|
— | — |
|
|
||||||||||||||||||||||||||||||||||
| Other comprehensive loss | — | — | — | — |
(
|
— |
(
|
||||||||||||||||||||||||||||||||||
| March 31, 2022 | $ |
|
$ |
|
$ |
(
|
$ |
(
|
$ |
(
|
$ |
|
$ |
(
|
|||||||||||||||||||||||||||
| Vesting of RSUs, net of tax withholdings and other | — | — | — | — | — | — |
|
||||||||||||||||||||||||||||||||||
| Purchase of treasury stock | — | — | — |
(
|
— | — |
(
|
||||||||||||||||||||||||||||||||||
| Purchase of SciPlay’s Class A common stock | — |
(
|
— | — | — |
(
|
(
|
||||||||||||||||||||||||||||||||||
| Stock-based compensation | — |
|
— | — | — | — |
|
||||||||||||||||||||||||||||||||||
| Net income | — | — |
|
— | — |
|
|
||||||||||||||||||||||||||||||||||
|
Other comprehensive loss
(1)
|
— | — | — | — |
(
|
— |
(
|
||||||||||||||||||||||||||||||||||
| June 30, 2022 | $ |
|
$ |
|
$ |
|
$ |
(
|
$ |
(
|
$ |
|
$ |
|
|||||||||||||||||||||||||||
| Vesting of RSUs, net of tax withholdings and other | — |
(
|
— | — | — | — |
(
|
||||||||||||||||||||||||||||||||||
| Purchase of SciPlay’s Class A common stock |
(
|
(
|
(
|
||||||||||||||||||||||||||||||||||||||
| Stock-based compensation | — |
|
— | — | — |
|
|
||||||||||||||||||||||||||||||||||
| Net income | — | — |
|
— | — |
|
|
||||||||||||||||||||||||||||||||||
|
Other comprehensive loss
(1)
|
— | — | — | — |
(
|
— |
(
|
||||||||||||||||||||||||||||||||||
| September 30, 2022 | $ |
|
$ |
|
$ |
|
$ |
(
|
$ |
(
|
$ |
|
$ |
|
|||||||||||||||||||||||||||
|
|
|||||||||||||||||||||||||||||||||||||||||
| Three Months Ended September 30, | Nine Months Ended September 30, | ||||||||||||||||||||||
| 2023 | 2022 | 2023 | 2022 | ||||||||||||||||||||
| Related to L&W stock options | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
| Related to L&W RSUs |
|
|
|
|
|||||||||||||||||||
| Related to SciPlay RSUs |
|
|
|
|
|||||||||||||||||||
|
Total
(1)
|
$ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
|
|
|||||||||||||||||||||||
| Number of Restricted Stock Units | Weighted Average Grant Date Fair Value | ||||||||||
|
Unvested RSUs as of December 31, 2022
|
|
$ |
|
||||||||
| Granted |
|
$ |
|
||||||||
| Vested |
(
|
$ |
|
||||||||
| Cancelled |
(
|
$ |
|
||||||||
|
Unvested RSUs as of September 30, 2023
|
|
$ |
|
||||||||
| As of | |||||||||||||||||
| September 30, 2023 | December 31, 2022 | ||||||||||||||||
| Operating lease right-of-use assets | $ |
|
$ |
|
|||||||||||||
| Accrued liabilities |
|
|
|||||||||||||||
| Operating lease liabilities |
|
|
|||||||||||||||
| Total operating lease liabilities | $ |
|
$ |
|
|||||||||||||
| Weighted average remaining lease term, units in years |
|
|
|||||||||||||||
| Weighted average discount rate |
|
% |
|
% | |||||||||||||
| Nine Months Ended September 30, | |||||||||||||||||
| 2023 | 2022 | ||||||||||||||||
| Cash paid for amounts included in the measurement of lease liabilities: | |||||||||||||||||
|
Operating cash flows for operating leases
|
$ |
|
$ |
|
|||||||||||||
| Right-of-use assets obtained in exchange for new lease liabilities: | |||||||||||||||||
|
Operating leases
|
$ |
|
$ |
|
|||||||||||||
| Remainder of 2023 | 2024 | 2025 | 2026 | 2027 | Thereafter | Less Imputed Interest | Total | ||||||||||||||||||||||||||||||||||||||||
| Operating leases | $ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
(
|
$ |
|
|||||||||||||||||||||||||||||||
|
Three Months Ended
September 30, |
Variance
|
Nine Months Ended
September 30, |
Variance
|
||||||||||||||||||||||||||||||||||||||||||||
| ($ in millions) | 2023 |
|
2022 | 2023 vs. 2022 | 2023 | 2022 | 2023 vs. 2022 | ||||||||||||||||||||||||||||||||||||||||
|
Total revenue
|
$ | 731 | $ | 648 | $ | 83 | 13 | % | $ | 2,131 | $ | 1,830 | $ | 301 | 16 | % | |||||||||||||||||||||||||||||||
| Total operating expenses | 584 | 559 | 25 | 4 | % | 1,769 | 1,655 | 114 | 7 | % | |||||||||||||||||||||||||||||||||||||
| Operating income | 147 | 89 | 58 | 65 | % | 362 | 175 | 187 | 107 | % | |||||||||||||||||||||||||||||||||||||
| Net income (loss) from continuing operations before income taxes | 94 | 24 | 70 | 292 | % | 139 | (189) | 328 | 174 | % | |||||||||||||||||||||||||||||||||||||
| Net income (loss) from continuing operations | 80 | 20 | 60 | 300 | % | 112 | (197) | 309 | 157 | % | |||||||||||||||||||||||||||||||||||||
|
Net income from discontinued operations, net of tax
(1)
|
— | 315 | (315) | nm | — | 3,855 | (3,855) | nm | |||||||||||||||||||||||||||||||||||||||
| Net income attributable to L&W | 75 | 328 | (253) | nm | 96 | 3,645 | (3,549) | nm | |||||||||||||||||||||||||||||||||||||||
| nm = not meaningful. | |||||||||||||||||||||||||||||||||||||||||||||||
|
(1) The three months ended September 30, 2022 include a pre-tax gain of $362 million on the sale of the Sports Betting Business, and the nine months ended September 30, 2022 include a total pre-tax gain of $4,930 million on the Divestitures (see Note 2).
|
|||||||||||||||||||||||||||||||||||||||||||||||
| Consolidated Revenue by Business Segment | ||||||||||||||
| (in millions) | ||||||||||||||
|
Three Months Ended September 30, 2023 and 2022
|
Nine Months Ended September 30, 2023 and 2022
|
|||||||||||||
|
Three Months Ended
September 30, |
Variance
|
Nine Months Ended
September 30, |
Variance
|
||||||||||||||||||||||||||||||||||||||||||||
| ($ in millions) | 2023 |
|
2022 | 2023 vs. 2022 | 2023 |
|
2022 | 2023 vs. 2022 | |||||||||||||||||||||||||||||||||||||||
| Operating expenses: | |||||||||||||||||||||||||||||||||||||||||||||||
| Cost of services | $ | 113 | $ | 101 | $ | 12 | 12 | % | $ | 331 | $ | 283 | $ | 48 | 17 | % | |||||||||||||||||||||||||||||||
| Cost of products | 105 | 92 | 13 | 14 | % | 307 | 251 | 56 | 22 | % | |||||||||||||||||||||||||||||||||||||
| Selling, general and administrative | 204 | 181 | 23 | 13 | % | 599 | 535 | 64 | 12 | % | |||||||||||||||||||||||||||||||||||||
| Research and development | 55 | 56 | (1) | (2) | % | 168 | 163 | 5 | 3 | % | |||||||||||||||||||||||||||||||||||||
| Depreciation, amortization and impairments | 90 | 102 | (12) | (12) | % | 298 | 317 | (19) | (6) | % | |||||||||||||||||||||||||||||||||||||
| Restructuring and other | 17 | 27 | (10) | (37) | % | 66 | 106 | (40) | (38) | % | |||||||||||||||||||||||||||||||||||||
|
Total operating expenses
|
$ | 584 | $ | 559 | $ | 25 | 4 | % | $ | 1,769 | $ | 1,655 | $ | 114 | 7 | % | |||||||||||||||||||||||||||||||
| Three Months Ended September 30, | Nine Months Ended September 30, | Factors Affecting Net Income Attributable to L&W | |||||||||||||||||||||||||||
| (in millions) | 2023 | 2022 | 2023 | 2022 | 2023 vs. 2022 | ||||||||||||||||||||||||
| Interest expense | $ | (78) | $ | (68) | $ | (231) | $ | (254) |
The increase in interest expense for the three months ended September 30, 2023 is primarily due to rising interest rates impacting the LNWI Term Loan B. The decrease in interest expense for the nine months ended September 30, 2023 is primarily due to lower outstanding debt resulting from the redemption of certain senior notes and refinancing through the LNWI Credit Agreement completed in the second quarter of 2022.
|
||||||||||||||||||||
| Loss on debt financing transactions | (15) | — | (15) | (147) | Loss on debt financing transactions included charges of $12 million in the third quarter of 2023 and $90 million in the second quarter of 2022 associated with premiums paid to redeem certain senior notes (see Note 11). | ||||||||||||||||||||||||
| Gain on remeasurement of debt and other | — | — | — | 27 | Gains are attributable to remeasurement of previously held Euro-denominated senior notes and reflect changes in the Euro vs. the U.S. Dollar foreign exchange rates. These notes were redeemed during the second quarter of 2022. | ||||||||||||||||||||||||
| Other income, net | 40 | 3 | 23 | 10 | The increase in other income was primarily due to the impact of changes in foreign currency exchange rates. | ||||||||||||||||||||||||
|
Three Months Ended September 30,
|
Nine Months Ended September 30, | ||||||||||||||||||||||||||||||||||||||||||||||
| 2023 | 2022 | 2023 | 2022 | ||||||||||||||||||||||||||||||||||||||||||||
|
($ in millions)
|
Revenue | % Consolidated Revenue | Revenue | % Consolidated Revenue | Revenue | % Consolidated Revenue | Revenue | % Consolidated Revenue | |||||||||||||||||||||||||||||||||||||||
| Foreign Currency: | |||||||||||||||||||||||||||||||||||||||||||||||
| British Pound Sterling | $ | 41 | 6 | % | $ | 34 | 5 | % | $ | 122 | 6 | % | $ | 118 | 6 | % | |||||||||||||||||||||||||||||||
| Euro | 56 | 8 | % | 49 | 8 | % | 169 | 8 | % | 145 | 8 | % | |||||||||||||||||||||||||||||||||||
| Australian Dollar | 54 | 7 | % | 35 | 5 | % | 151 | 7 | % | 72 | 4 | % | |||||||||||||||||||||||||||||||||||
|
Three and Nine Months Ended September 30, 2023 and 2022
|
||
|
Three Months Ended
September 30, |
Variance
|
Nine Months Ended
September 30, |
Variance
|
||||||||||||||||||||||||||||||||||||||||||||
| ($ in millions) | 2023 | 2022 | 2023 vs. 2022 | 2023 | 2022 | 2023 vs. 2022 | |||||||||||||||||||||||||||||||||||||||||
| Revenue: | |||||||||||||||||||||||||||||||||||||||||||||||
|
Gaming operations
|
$ | 166 | $ | 161 | $ | 5 | 3 | % | $ | 493 | $ | 479 | $ | 14 | 3 | % | |||||||||||||||||||||||||||||||
|
Machine sales
|
172 | 140 | 32 | 23 | % | 503 | 366 | 137 | 37 | % | |||||||||||||||||||||||||||||||||||||
|
Systems
|
71 | 70 | 1 | 1 | % | 197 | 181 | 16 | 9 | % | |||||||||||||||||||||||||||||||||||||
|
Table products
|
56 | 48 | 8 | 17 | % | 161 | 137 | 24 | 18 | % | |||||||||||||||||||||||||||||||||||||
|
Total revenue
|
$ | 465 | $ | 419 | $ | 46 | 11 | % | $ | 1,354 | $ | 1,163 | $ | 191 | 16 | % | |||||||||||||||||||||||||||||||
|
F/X impact on revenue
|
$ | 2 | $ | (9) | $ | 11 | 122 | % | $ | (4) | $ | (19) | $ | 15 | 79 | % | |||||||||||||||||||||||||||||||
| Gaming KPIs: | |||||||||||||||||||||||||||||||||||||||||||||||
| U.S. and Canada units: | |||||||||||||||||||||||||||||||||||||||||||||||
| Installed base at period end | 31,035 | 30,536 | 499 | 2 | % | 31,035 | 30,536 | 499 | 2 | % | |||||||||||||||||||||||||||||||||||||
| Average daily revenue per unit | $ | 47.57 | $ | 45.68 | $ | 1.89 | 4 | % | $ | 46.80 | $ | 44.99 | $ | 1.81 | 4 | % | |||||||||||||||||||||||||||||||
|
International units
(1)
:
|
|||||||||||||||||||||||||||||||||||||||||||||||
| Installed base at period end | 22,442 | 28,100 | (5,658) | (20) | % | 22,442 | 28,100 | (5,658) | (20) | % | |||||||||||||||||||||||||||||||||||||
| Average daily revenue per unit | $ | 14.01 | $ | 12.39 | $ | 1.62 | 13 | % | $ | 14.87 | $ | 13.25 | $ | 1.62 | 12 | % | |||||||||||||||||||||||||||||||
| Gaming machine unit sales: | |||||||||||||||||||||||||||||||||||||||||||||||
| U.S. and Canada new unit shipments | 4,640 | 4,400 | 240 | 5 | % | 13,717 | 11,791 | 1,926 | 16 | % | |||||||||||||||||||||||||||||||||||||
| International new unit shipments | 4,045 | 2,859 | 1,186 | 41 | % | 11,796 | 7,252 | 4,544 | 63 | % | |||||||||||||||||||||||||||||||||||||
| Total new unit shipments | 8,685 | 7,259 | 1,426 | 20 | % | 25,513 | 19,043 | 6,470 | 34 | % | |||||||||||||||||||||||||||||||||||||
| Average sales price per new unit | $ | 18,104 | $ | 17,359 | $ | 745 | 4 | % | $ | 18,062 | $ | 17,224 | $ | 838 | 5 | % | |||||||||||||||||||||||||||||||
| (1) Units exclude those related to game content licensing. | |||||||||||||||||||||||||||||||||||||||||||||||
|
Three Months Ended
September 30, |
Variance
|
Nine Months Ended
September 30, |
Variance
|
||||||||||||||||||||||||||||||||||||||||||||
| 2023 | 2022 | 2023 vs. 2022 | 2023 | 2022 | 2023 vs. 2022 | ||||||||||||||||||||||||||||||||||||||||||
| U.S. and Canada unit shipments: | |||||||||||||||||||||||||||||||||||||||||||||||
| Replacement units | 4,542 | 3,688 | 854 | 23 | % | 12,900 | 10,209 | 2,691 | 26 | % | |||||||||||||||||||||||||||||||||||||
| Casino opening and expansion units | 98 | 712 | (614) | (86) | % | 817 | 1,582 | (765) | (48) | % | |||||||||||||||||||||||||||||||||||||
| Total unit shipments | 4,640 | 4,400 | 240 | 5 | % | 13,717 | 11,791 | 1,926 | 16 | % | |||||||||||||||||||||||||||||||||||||
| International unit shipments: | |||||||||||||||||||||||||||||||||||||||||||||||
| Replacement units | 3,262 | 2,725 | 537 | 20 | % | 9,371 | 7,082 | 2,289 | 32 | % | |||||||||||||||||||||||||||||||||||||
| Casino opening and expansion units | 783 | 134 | 649 | 484 | % | 2,425 | 170 | 2,255 | 1,326 | % | |||||||||||||||||||||||||||||||||||||
| Total unit shipments | 4,045 | 2,859 | 1,186 | 41 | % | 11,796 | 7,252 | 4,544 | 63 | % | |||||||||||||||||||||||||||||||||||||
|
Three and Nine Months Ended September 30, 2023 and 2022
|
||
|
Three Months Ended
September 30, |
Variance
|
Nine Months Ended
September 30, |
Variance
|
||||||||||||||||||||||||||||||||||||||||||||
| (in millions unless otherwise noted) | 2023 | 2022 | 2023 vs. 2022 | 2023 | 2022 | 2023 vs. 2022 | |||||||||||||||||||||||||||||||||||||||||
| Revenue: | |||||||||||||||||||||||||||||||||||||||||||||||
|
Mobile in-app purchases
|
$ | 173 | $ | 149 | $ | 24 | 16 | % | $ | 509 | $ | 426 | $ | 83 | 19 | % | |||||||||||||||||||||||||||||||
|
Web in-app purchases and other
(1)
|
23 | 22 | 1 | 5 | % | 64 | 63 | 1 | 2 | % | |||||||||||||||||||||||||||||||||||||
|
Total revenue
|
$ | 196 | $ | 171 | $ | 25 | 15 | % | $ | 573 | $ | 489 | $ | 84 | 17 | % | |||||||||||||||||||||||||||||||
| SciPlay KPIs: | |||||||||||||||||||||||||||||||||||||||||||||||
| In-App Purchases: | |||||||||||||||||||||||||||||||||||||||||||||||
|
Mobile Penetration
(2)
|
90 | % | 90 | % | — | nm | 91 | % | 90 | % | 1 pp | nm | |||||||||||||||||||||||||||||||||||
|
Average MAU
(3)
|
5.7 | 5.9 | (0.2) | (3) | % | 5.8 | 6.0 | (0.2) | (3) | % | |||||||||||||||||||||||||||||||||||||
|
Average DAU
(4)
|
2.2 | 2.2 | — | — | % | 2.2 | 2.3 | (0.1) | (4) | % | |||||||||||||||||||||||||||||||||||||
|
ARPDAU
(5)
|
$ | 0.96 | $ | 0.80 | $ | 0.16 | 20 | % | $ | 0.93 | $ | 0.76 | $ | 0.17 | 22 | % | |||||||||||||||||||||||||||||||
|
Average MPU
(6)
(in thousands)
|
602 | 577 | 25 | 4 | % | 612 | 566 | 46 | 8 | % | |||||||||||||||||||||||||||||||||||||
|
AMRPPU
(7)
|
$ | 106.61 | $ | 95.45 | $ | 11.16 | 12 | % | $ | 102.03 | $ | 92.97 | $ | 9.06 | 10 | % | |||||||||||||||||||||||||||||||
|
Payer Conversion Rate
(8)
|
10.6 | % | 9.7 | % | 0.9 pp | nm | 10.5 | % | 9.4 | % | 1.1 pp | nm | |||||||||||||||||||||||||||||||||||
|
nm = not meaningful.
pp = percentage points.
(1) Other primarily represents advertising revenue, which was not material in the periods presented.
(2) Mobile penetration is defined as the percentage of business to consumer revenue generated from mobile platforms.
(3) MAU = Monthly Active Users is a count of visitors to SciPlay sites during a month. An individual who plays multiple games or from multiple devices may, in certain circumstances, be counted more than once. However, SciPlay uses third-party data to limit the occurrence of multiple counting.
(4) DAU = Daily Active Users is a count of visitors to SciPlay sites during a day. An individual who plays multiple games or from multiple devices may, in certain circumstances, be counted more than once. However, SciPlay uses third-party data to limit the occurrence of multiple counting.
(5) ARPDAU = Average Revenue Per DAU is calculated by dividing revenue for a period by the DAU for the period by the number of days for the period.
(6) MPU = Monthly Paying Users is the number of individual users who made an in-game purchase during a particular month.
(7) AMRPPU = Average Monthly Revenue Per Paying User is calculated by dividing average monthly revenue by average MPUs for the applicable time period.
(8) Payer conversion rate is calculated by dividing average MPU for the period by the average MAU for the same period.
|
|||||||||||||||||||||||||||||||||||||||||||||||
|
Three and Nine Months Ended September 30, 2023 and 2022
|
||
| (in millions) | Cash and cash equivalents | Revolver capacity | Revolver capacity drawn or committed to letters of credit | Total | ||||||||||||||||||||||
| L&W (excluding SciPlay) | $ | 485 | $ | 750 | $ | (11) | $ | 1,224 | ||||||||||||||||||
| SciPlay | 406 | 150 | — | 556 | ||||||||||||||||||||||
|
Total as of September 30, 2023
|
$ | 891 | $ | 900 | $ | (11) | $ | 1,780 | ||||||||||||||||||
| L&W (excluding SciPlay) | $ | 584 | $ | 750 | $ | (12) | $ | 1,322 | ||||||||||||||||||
| SciPlay | 330 | 150 | — | 480 | ||||||||||||||||||||||
|
Total as of December 31, 2022
|
$ | 914 | $ | 900 | $ | (12) | $ | 1,802 | ||||||||||||||||||
| Nine Months Ended September 30, |
Variance
|
||||||||||||||||
|
($ in millions)
|
2023 | 2022 | 2023 vs. 2022 | ||||||||||||||
| Net cash provided by (used in) operating activities from: | |||||||||||||||||
| Continuing operations | $ | 423 | $ | (346) | $ | 769 | |||||||||||
| Discontinued operations | — | 52 | (52) | ||||||||||||||
| Net cash provided by (used in) operating activities | 423 | (294) | 717 | ||||||||||||||
| Net cash (used in) provided by investing activities from: | |||||||||||||||||
| Continuing operations | (187) | (224) | 37 | ||||||||||||||
| Discontinued operations | (3) | 6,368 | (6,371) | ||||||||||||||
| Net cash (used in) provided by investing activities | (190) | 6,144 | (6,334) | ||||||||||||||
| Net cash used in financing activities from: | |||||||||||||||||
| Continuing operations | (251) | (5,210) | 4,959 | ||||||||||||||
| Discontinued operations | — | (3) | 3 | ||||||||||||||
| Net cash used in financing activities | (251) | (5,213) | 4,962 | ||||||||||||||
| Effect of exchange rate changes on cash, cash equivalents and restricted cash | (2) | (12) | 10 | ||||||||||||||
| (Decrease) increase in cash, cash equivalents and restricted cash | $ | (20) | $ | 625 | $ | (645) | |||||||||||
| Nine Months Ended September 30, |
Variance
|
||||||||||||||||
|
($ in millions)
|
2023 | 2022 | 2023 vs. 2022 | ||||||||||||||
| Net income | $ | 112 | $ | 3,658 | $ | (3,546) | |||||||||||
| Less: Income from discontinued operations, net of tax | — | (3,855) | 3,855 | ||||||||||||||
| Adjustments to reconcile net income (loss) from continuing operations to net cash provided by (used in) operating activities from continuing operations | 436 | 488 | (52) | ||||||||||||||
| Changes in working capital accounts, excluding the effects of acquisitions | (81) | (641) | 560 | ||||||||||||||
| Changes in deferred income taxes and other | (44) | 4 | (48) | ||||||||||||||
|
Net cash provided by (used in) operating activities from continuing operations
|
$ | 423 | $ | (346) | $ | 769 | |||||||||||
| (in millions, except for price per share) | ||||||||||||||||||||||||||
| ISSUER PURCHASES OF EQUITY SECURITIES | ||||||||||||||||||||||||||
| Period |
Total Number of Shares
Purchased as Part of Publicly Announced Program |
Average Price Paid per Share
(1)
|
Total Cost of Repurchase
(in millions)
(1)
|
Approximate Dollar Value of Shares that May Yet Be Purchased Under the Program (in millions)
(1)
|
||||||||||||||||||||||
| 7/1/2023 - 7/31/2023 | 0.3 | $ | 69.58 | $ | 19 | $ | 293 | |||||||||||||||||||
| 8/1/2023 - 8/31/2023 | 1.2 | $ | 74.82 | $ | 93 | $ | 200 | |||||||||||||||||||
| 9/1/2023 - 9/30/2023 | — | $ | — | $ | — | $ | 200 | |||||||||||||||||||
| Total | 1.5 | $ | 73.87 | $ | 112 | $ | 200 | |||||||||||||||||||
|
(1) Average price paid per share is calculated on a settlement basis and excludes excise tax. As of January 1, 2023, our share repurchases in excess of issuances are subject to a 1% excise tax enacted by the Inflation Reduction Act. Any excise tax incurred is recognized in stockholders’ equity as part of the cost basis of the shares acquired. For the three months ended September 30, 2023, excise taxes totaled $1 million.
|
||||||||||||||||||||||||||
|
Exhibit
Number |
Description | |||||||
| 2.1* | ||||||||
| 3.1 | ||||||||
| 3.2 | ||||||||
| 4.1 | ||||||||
| 10.1 | ||||||||
| 31.1 | ||||||||
| 31.2 | ||||||||
| 32.1 | ||||||||
| 32.2 | ||||||||
| 101.INS | Inline XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document. | |||||||
| 101.SCH | Inline XBRL Taxonomy Extension Schema Document | |||||||
| 101.CAL | Inline XBRL Taxonomy Extension Calculation Linkbase Document | |||||||
| 101.DEF | Inline XBRL Taxonomy Extension Definition Label Linkbase Document | |||||||
| 101.LAB | Inline XBRL Taxonomy Extension Label Linkbase Document | |||||||
| 101.PRE | Inline XBRL Taxonomy Extension Presentation Linkbase Document | |||||||
| 104 | Cover Page Interactive Data File - the cover page interactive data file does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document. | |||||||
|
LIGHT & WONDER, INC.
|
|||||||||||
|
(Registrant)
|
|||||||||||
|
By:
|
/s/ Oliver Chow
|
||||||||||
|
Name:
|
Oliver Chow
|
||||||||||
|
Title:
|
Senior Vice President, Interim Chief Financial Officer, and Principal Financial Officer
|
||||||||||
|
Dated:
|
November 9, 2023
|
||||||||||
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|